Lilly(Eli) & Co (LLY) Stock Price, Graph, News & Analysis
() | NEW YORK STOCK EXCHANGE INC. : LLY
$732.08 -$13.87 (-1.86%)
Market Status : Open
Last Update :
4/19/2024 11:06:37 AM
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was Read More
Historical Price Graph
Performance
| 1 Month | 3 Month | 6 Month | YTD | 1 Year | 3 Year | 5 Year |
|---|---|---|---|---|---|---|
| -2.19% | 19.88% | 23.29% | 28.19% | 103.35% | 154.92% | 599.33% |
Details
Exchange
NEW YORK STOCK EXCHANGE INC.
Industry
Website
https://www.lilly.com/
Sector
CEO
David Ricks
Total Employees
39,000
SIC Code
2834
Market Cap
$ 695.60 B
Key Statistics
Dividend Rate
$4.68
Last Dividend
2024-02-14
Dividend Yield
0.63%
P/E Ratio
126.22
Price Range (52 Week)
$367.60 - $800.78
Latest Volume
$ 1.15 M
Average Total Volume
$ 2.38 M
Outstanding Shares
950,164,452
Beta
62.86%
Similar Stocks
| Companyarrow_upward | Sectorarrow_upward | Latest Pricearrow_upward | Changearrow_upward |
|---|---|---|---|
| Broadcom Inc (AVGO) | Electronic Technology | $1,235.90 | -$23.09 |
| Meta Platforms Inc - Class A (FB) | Technology Services | $196.64 | $0.99 |
| JPMorgan Chase & Co. - FR SP ETN REDEEM 24/05/2024 USD 19.03661 (AMJ) | Miscellaneous | $28.14 | $0.53 |
| JPMorgan Chase & Co. (JPM) | Finance | $182.60 | $1.35 |
| Visa Inc - Class A (V) | Finance | $269.69 | -$1.69 |
Lilly(Eli) & Co in News
STAT News (LLY,AZN-LN,AZN,ZEGA-GD,ZEGA-GB,ZEGA-GM,ZEGA-GS,ZEGA-GF,AZNCF,AZN-SS,FDA-IM)
STAT+: Pharmalittle: FDA rejects Lilly drug studied only in China; AstraZeneca suffers a setback with a key cancer drug The Food and Drug Administration declined to approve an Eli Lilly (LLY) lung cancer drug that had be Mar 24, 2022 9:21 AM
Benzinga (LLY)
Insiders Sell About $138M Of 5 Stocks The Russian ruble declined against the US dollar on Monday after the Moscow Exchange resumed trading Mar 21, 2022 8:32 AM
Seeking Alpha (LLY)
Lilly, Boehringer Ingelheim''s Jardiance gets EU approval for expanded use in heart failure The European Commission ((EC)) approved the expanded use of Eli Lilly (LLY) and Boehringer Ingelheim Mar 8, 2022 5:42 AM
MarketWatch (LLY,RHHBY,INCY)
Preliminary U.K. research says Lilly drug can reduce the risk of death among severely ill COVID-19 patients A new study found that baricitinib, a rheumatoid arthritis drug developed by Eli Lilly & Co. and Inc Mar 4, 2022 10:50 AM
Seeking Alpha (LLY,INCY)
Lilly/Incyte''s baricitinib reduces risk of death in COVID patients in UK study- Reuters A U.K. study showed that Eli Lilly (LLY) Incyte''s (INCY) Olumiant (baricitinib) helped reduce the r Mar 4, 2022 4:48 AM
Dakota Financial News (LLY)
Eli Lilly and Company (NYSE:LLY) Shares Bought by Benjamin Edwards Inc. Benjamin Edwards Inc. raised its stake in Eli Lilly and Company (NYSE:LLY) by 20.0% during the third Dec 24, 2021 10:04 AM
Seeking Alpha (LLY,LOW)
Stocks To Watch: Rivian Earnings, Samsara IPO And Events For Delta, Lowe''s And Eli Lilly No summary available. Dec 11, 2021 9:53 AM
Transcript Daily (LLY,JPM)
Wells Fargo & Company Begins Coverage on Eli Lilly and (NYSE:LLY) Wells Fargo & Company initiated coverage on shares of Eli Lilly and (NYSE:LLY) in a research note pu Dec 11, 2021 4:50 AM
OpenPR (JNJ,NVS,NOVN-SE,LLY,GSK-LN,GSK,ROG-SE,RHHBY,RO-SE,MRK,MRK-GY,MRK-GH,MRK-GD,MRK-GF,MRK-GM,MRK-GS,MRK-GI,MRK-GB,MKGAF,MKKGY,SNY,SAN-FP)
Medicine of Bioengineered Protein Market Notable Growth in CAGR +8% by end 2027|| GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Sanofi, Eli Lilly, Roche A Proteins play a crucial role in preserving both the physical and practical aspects of a specific c Dec 7, 2021 3:02 AM
PR Newswire Asia (English) (INCY,LLY)
Innovent Releases Results of a Phase 1 Clinical Study of IBI362, a Dual Glucagon-like Peptide-1 and Glucagon Receptor Agonist in Chinese Patients with Type 2 Diabetes at the International Diabetes Federation Congress 2021 SAN FRANCISCO and SUZHOU, China , Dec. 7, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") Dec 6, 2021 7:00 PM
Common Questions Related to Lilly(Eli) & Co
When is Lilly(Eli) & Co next earning date?
Lilly(Eli) & Co next earning date is 2024-04-30
What is dividend yield of Lilly(Eli) & Co stock?
Lilly(Eli) & Co dividend yield is 0.00627052629742387 and Lilly(Eli) & Co announced last dividend in 2024-02-14 of amount $4.68/stock.
What is Lilly(Eli) & Co stock symbol?
Lilly(Eli) & Co traded in NEW YORK STOCK EXCHANGE INC. stock exchange and the stock symbol/ticker is LLY
What is the latest share price of Lilly(Eli) & Co (LLY)? or What is Lilly(Eli) & Co stock price today?
Lilly(Eli) & Co latest stock price is $732.08
Where is Lilly(Eli) & Co headquarter?
Lilly(Eli) & Co headquarter is at – Lilly Corporate Ctr, Indianapolis, Indiana, US
What is the total market cap of Lilly(Eli) & Co company?
The total market value of Lilly(Eli) & Co stock is $ 708.78 B
What is the P/E ratio of Lilly(Eli) & Co stock?
Lilly(Eli) & Co P/E ratio is 135.25211300080147
What is the EPS of Lilly(Eli) & Co stock?
Lilly(Eli) & Co EPS is 5.8
What is the Beta of Lilly(Eli) & Co stock?
Lilly(Eli) & Co Beta is 0.6285972489703746
Related Tags
Lilly(Eli) & Co stock price history, Lilly(Eli) & Co stock quote, LLY current stock price, Lilly(Eli) & Co dividend yield, Lilly(Eli) & Co Dividend, How much is Lilly(Eli) & Co worth